Analyst stock forecast
Supernus Pharmaceuticals Forecast: $61.75 Analyst Target
Direct answer
Supernus Pharmaceuticals's average price target is $61.75.
The target implies +43.5% from the recorded current price, and the consensus rating is none.
The low target implies +27.8%, the high target implies +55.7%, and the range spans 27.9% of the current price.
Forecast evidence checked October 1, 2026.
Get free Supernus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $43.04
- Average price target
- $61.75
- High price target
- $67.00
- Low price target
- $55.00
- Low target gap
- +27.8%
- Target upside
- +43.5%
- High target gap
- +55.7%
- Target range width
- 27.9%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- October 1, 2026
- Valid through
- October 8, 2026
Explore related company data
Read the frequently asked questions.
What is Supernus Pharmaceuticals's average price target?
Supernus Pharmaceuticals's verified average price target is $61.75. The target range is $55.00 to $67.00.
How far are Supernus Pharmaceuticals's low and high targets from the recorded price?
The low target implies +27.8%, while the high target implies +55.7%.
How many analysts are included in Supernus Pharmaceuticals's consensus?
The verified consensus includes 4 analysts.
How is Supernus Pharmaceuticals's target upside or downside calculated?
The average target of $61.75 is divided by the recorded price of $43.04, then one is subtracted to produce +43.5%. This does not guarantee a future return.
When was Supernus Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-10-01. The dataset is valid through 2026-10-08.